Bendamustine
Drug timelines are a Plus or Pro feature.
161 regulatory and trial events tracked for Bendamustine, covering 2010-10-21 to 2026-06-24. Get the full timeline:
Most recent: Clinical Trial Results: Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) [Phase 1, Phase 2]